A fully-covered stent (Alimaxx-E) for the palliation of malignant dysphagia: a prospective follow-up study

Background: The majority of the Currently available metal stents are partially covered to reduce migration risk. However, one of the remaining issues is tissue ingrowth through the uncovered stent parts. Objective: To determine efficacy, recurrent dysphagia, and complications of a fully covered stent, ie, the Alimaxx-E stent, and to compare two stent delivery systems, ie, one introducing the stent over a guidewire and One introducing the stent over a small-caliber endoscope. Design: A prospective, follow-up study evaluating a new stent design, with randomization for type of introduction system. Setting: Three tertiary referral centers. Patients: Forty-five patients with inoperable or metastatic esophageal or gastric cardia cancer. Interventions: Stent placement. Main Outcome Measurements: (1) Functional outcome, recurrent dysphagia, complications, and mortality of the Alimaxx-E stent; (2) functional aspects of the delivery system. Results: At 4 weeks after stent placement, the dysphagia score improved in all patients (P < .001). Twenty-two of 45 patients (49%) developed among them 28 episodes of recurrent dysphagia, predominantly stent migration (n = 16). Major complications Occurred in 9 of 45 patients (20%), with all 5 early (< 1 week) complications (severe pain [n = 3], hemorrhage [n = 1], and fever [n = 1]) occurring in patients in whom the stent was introduced over the endoscope (P = .02). During follow-up, 44 patients died, 3 (7%) from hemorrhage. Limitation: The Alimaxx-E stent was randomly compared with other stent designs. Conclusions: Placement of Alimaxx-E stents is safe and produces long-cerin relief of dysphagia, particularly When introduced over a guidewire. The migration rate of the Alimaxx-E stent is, however, unacceptably high, and an adapted stent design is needed. (Gastrointest Endosc 2009;70: 1082-9.)